Annual report for Procter & Gamble Health Ltd. for FY-2014
01-02-2014
Board to consider Dividend
Merck Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 31, 2014 to consider and approve the Audited Financial Results for the quarter & year ended December 31, 2013 and to consider recommendation of dividend for the year 2013.09-01-2014
Financial Results & Limited Review for Sep 30, 2013
Merck Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2013.23-10-2013
Financial Results & Limited Review for June 30, 2013
Merck Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2013.29-07-2013
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Merck Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199210-07-2013
Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Homi C H Bhabha has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 199210-07-2013
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
SBI Funds Management Pvt Ltd and has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201103-06-2013
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Merck Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199227-05-2013
Limited Review for March 31, 2013
Merck Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended March 31, 2013.02-05-2013
Financial Results for March 31, 2013
Merck Ltd has informed BSE about the Financial Results for the period ended March 31, 2013.26-04-2013